Compare RNAC & ROMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNAC | ROMA |
|---|---|---|
| Founded | 2007 | 2018 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 175.8M | 144.7M |
| IPO Year | 2016 | 2024 |
| Metric | RNAC | ROMA |
|---|---|---|
| Price | $6.68 | $1.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $38.40 | N/A |
| AVG Volume (30 Days) | ★ 232.2K | 6.4K |
| Earning Date | 11-06-2025 | 12-26-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,091,000.00 | ★ $1,640,101.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 59.60 |
| 52 Week Low | $5.98 | $0.58 |
| 52 Week High | $20.12 | $4.66 |
| Indicator | RNAC | ROMA |
|---|---|---|
| Relative Strength Index (RSI) | 41.10 | 36.09 |
| Support Level | $6.40 | $1.83 |
| Resistance Level | $9.23 | $2.59 |
| Average True Range (ATR) | 0.69 | 0.28 |
| MACD | -0.10 | -0.04 |
| Stochastic Oscillator | 12.01 | 49.14 |
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.
Roma Green Finance Ltd is principally engaged in the provision of ESG, corporate governance and risk management as well as sustainability and climate change-related advisory services. The company works closely with its clients to help them understand, identify, manage, and overcome various business matters arising from such factors related to ESG, sustainability and climate change. Geographically, the company generates its revenue from Hong Kong and Singapore.